Friday - July 17, 2026
Antisense oligonucleotide strategy reverses HNRNPH2-related neurodevelopmental disorder
April 22, 2026
MEMPHIS, Tennessee, April 22 [Category: BizHospital] -- St. Jude Children's Research Hospital issued the following news release:

* * *

Antisense oligonucleotide strategy reverses HNRNPH2-related neurodevelopmental disorder

*

Scientists at St. Jude Children's Research Hospital have found they can reverse the effects of HNRNPH2 -related neurodevelopmental disorder using antisense oligonucleotides (ASOs) in preclinical models. ASOs are s . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products